These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4667466)

  • 21. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of whole and lysed sensitized lymphocytes on murine tumor growth and host survival.
    Greco RS; Schmidt DR; Storer EH
    Surg Forum; 1973; 24():109-11. PubMed ID: 4808028
    [No Abstract]   [Full Text] [Related]  

  • 23. Attempts to find human adenovirus type-12 tumor antigens in human tumors.
    McCormick KJ; Van Hoosier GL
    J Natl Cancer Inst; 1968 Feb; 40(2):255-61. PubMed ID: 5638607
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical results in cancer patients treated with an original technic of active immunotherapy].
    Alem C
    Boll Ist Sieroter Milan; 1971; 50(4):260-7. PubMed ID: 5163493
    [No Abstract]   [Full Text] [Related]  

  • 25. Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition.
    Fisher B; Soliman O; Fisher ER
    Cancer Res; 1970 Jul; 30(7):2035-42. PubMed ID: 4917210
    [No Abstract]   [Full Text] [Related]  

  • 26. A fresh look at tumor immunosurveillance and immunotherapy.
    Smyth MJ; Godfrey DI; Trapani JA
    Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.
    Suminoe A; Matsuzaki A; Hattori H; Koga Y; Hara T
    Pediatr Transplant; 2009 Sep; 13(6):746-53. PubMed ID: 19067917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to malignant disease in man.
    Fairley GH
    Sci Basis Med Annu Rev; 1971; ():17-38. PubMed ID: 4933915
    [No Abstract]   [Full Text] [Related]  

  • 30. The present status of immunodiagnosis and immunotherapy of cancer.
    Pasternak G
    Arch Geschwulstforsch; 1981; 51(4):284-93. PubMed ID: 7032448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. About human tumor antigens to be used in immunotherapy.
    Lucas S; Coulie PG
    Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunological aspects of tumor pathology].
    Piacentini G; Ferrari S
    Boll Ist Sieroter Milan; 1971; 50(3):199-208. PubMed ID: 5146577
    [No Abstract]   [Full Text] [Related]  

  • 33. Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor.
    Modak S; Gerald W; Cheung NK
    Med Pediatr Oncol; 2002 Dec; 39(6):547-51. PubMed ID: 12376975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor antigens and immune reactions against tumors].
    Trepel F
    Med Klin; 1971 Feb; 66(7):215-22. PubMed ID: 4928396
    [No Abstract]   [Full Text] [Related]  

  • 36. Animal models of cancer immunotherapy: questions of relevance.
    Weiss DW
    Cancer Treat Rep; 1980; 64(2-3):481-5. PubMed ID: 7407787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [NK cells--their role and importance in antitumor resistance].
    Mircheva Zh
    Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
    [No Abstract]   [Full Text] [Related]  

  • 38. Current developments in cancer vaccines and cellular immunotherapy.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
    Morera Y; Bequet-Romero M; Ayala M; Lamdán H; Agger EM; Andersen P; Gavilondo JV
    Angiogenesis; 2008; 11(4):381-93. PubMed ID: 19034678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Immune" RNA--a new model for the immunotherapy of cancer.
    Pilch YH
    Cancer Chemother Rep 3; 1973 Mar; 4(2):287-92. PubMed ID: 4729332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.